GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Long-Term Capital Lease Obligation

Novan (NOVNW) Long-Term Capital Lease Obligation : $3.39 Mil (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novan Long-Term Capital Lease Obligation?

Novan's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2023 was $3.39 Mil.

Novan's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 ($3.80 Mil) to Dec. 2022 ($3.74 Mil) and declined from Dec. 2022 ($3.74 Mil) to Mar. 2023 ($3.39 Mil).

Novan's annual Long-Term Capital Lease Obligation increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($3.61 Mil) and increased from Dec. 2021 ($3.61 Mil) to Dec. 2022 ($3.74 Mil).


Novan Long-Term Capital Lease Obligation Historical Data

The historical data trend for Novan's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan Long-Term Capital Lease Obligation Chart

Novan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only 8.01 5.10 - 3.61 3.74

Novan Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.90 3.70 3.80 3.74 3.39

Novan  (OTCPK:NOVNW) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Novan Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Novan's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Long-Term Capital Lease Obligation
Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Q2 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc SB206 Clinical Data Update Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc Fireside Chat Hosted by ROTH Transcript

By GuruFocus Research 02-14-2024

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Host Analyst and Investor Event Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

By sperokesalga sperokesalga 05-08-2023